| Report ID | 275622 |
| Drug Identification Number | 02363356 |
| Brand name | EMEND IV |
| Common or Proper name | fosaprepitant for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FOSAPREPITANT |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1DOSE |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-02-09 |
| Actual start date | 2026-01-13 |
| Estimated end date | 2026-02-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2026-01-14 | English | Compare |
| v4 | 2026-01-13 | French | Compare |
| v3 | 2026-01-13 | English | Compare |
| v2 | 2026-01-08 | French | Compare |
| v1 | 2026-01-08 | English | Compare |
Showing 1 to 5 of 5